Doximity, Inc. cash flow statement
In fiscal 2026, Doximity, Inc.'s operations generated $326m of cash; it spent $0 on capital projects, leaving free cash flow of $326m. It returned $432m through buybacks.
Cash flow statement
| Fiscal year | 2020Mar 2020 | 2021Mar 2021 | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 26 | 83 | 127 | 180 | 184 | 273 | 326 | 306 |
| Depreciation and amortisation | 1 | 4 | 5 | 10 | 10 | 11 | 14 | 12 |
| Stock-based pay | 2 | 7 | 31 | 48 | 51 | 72 | 122 | 137 |
| Capital spending | 0 | 0 | 2 | 2 | 0 | 0 | 0 | 0 |
| Free cash flow | 26 | 83 | 125 | 178 | 184 | 273 | 326 | 306 |
| Free cash flow after stock pay | 24 | 75 | 93 | 130 | 133 | 201 | 205 | 170 |
| Share buybacks | 0 | 2 | 3 | 85 | 281 | 120 | 432 | 401 |
| Quarter | 2025 Q2Sept 2024 | 2025 Q3Dec 2024 | 2025 Q4Mar 2025 | 2026 Q1Jun 2025 | 2026 Q2Sept 2025 | 2026 Q3Dec 2025 | 2026 Q4Mar 2026 | 2027 Q1Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 68 | 65 | 98 | 62 | 94 | 61 | 110 | 42 |
| Depreciation and amortisation | 2 | 2 | 3 | 3 | 2 | 2 | 4 | 4 |
| Stock-based pay | 18 | 19 | 18 | 22 | 29 | 34 | 37 | 37 |
| Capital spending | 0 | 0 | 0 | 0 | — | — | — | 0 |
| Free cash flow | 68 | 65 | 98 | 62 | — | — | — | 42 |
| Free cash flow after stock pay | 50 | 46 | 80 | 40 | — | — | — | 5 |
Compare with peers
- Goodrx Holdings, Inc. cash flow
- Phreesia, Inc. cash flow
- Genedx Holdings Corp. cash flow
- Omnicell, Inc. cash flow
- Waystar Holding Corp. cash flow
Head to head: DOCS vs GDRXDOCS vs PHRDOCS vs WGS
More: Health Care Technology stocks compared, Health Care sector, rankings of US companies